Cargando…
VX765, a Specific Caspase-1 Inhibitor, Alleviates Lung Ischemia Reperfusion Injury by Suppressing Endothelial Pyroptosis and Barrier Dysfunction
Lung ischemia reperfusion injury (LIRI) is a complex pathophysiological process with high morbidity and mortality. An important pathophysiological characteristic of LIRI is endothelial barrier dysfunction, although the mechanism involved in this process remains unclear. VX765, a specific caspase-1 i...
Autores principales: | Wu, Siyi, Li, Zhao, Ye, Mengling, Liu, Chunxia, Liu, Hao, He, Xiaojing, Qin, Yi, Liang, Fangte, Pan, Linghui, Lin, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716216/ https://www.ncbi.nlm.nih.gov/pubmed/34977239 http://dx.doi.org/10.1155/2021/4525988 |
Ejemplares similares
-
VX‐765 ameliorates renal injury and fibrosis in diabetes by regulating caspase‐1‐mediated pyroptosis and inflammation
por: Wen, Si, et al.
Publicado: (2021) -
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
por: Do Carmo, Helison, et al.
Publicado: (2018) -
VX-765 reduces neuroinflammation after spinal cord injury in mice
por: Chen, Jing, et al.
Publicado: (2021) -
Preconditioning with rHMGB1 ameliorates lung ischemia–reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway
por: Fei, Lin, et al.
Publicado: (2020) -
Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis
por: Jin, Ying, et al.
Publicado: (2022)